EP Patent

EP2016947A1 — Novel one step process for preparing cross-linked poly(allylamine) polymers

Assigned to Chemo Iberica SA · Expires 2009-01-21 · 17y expired

What this patent protects

The present invention relates to a novel one step process for preparing cross-linked poly(allylamine) polymers or salts thereof using the novel cross-linking agent of Formula (IV). This invention also relates to the compound of Formula (IV) as well as to a process to…

USPTO Abstract

The present invention relates to a novel one step process for preparing cross-linked poly(allylamine) polymers or salts thereof using the novel cross-linking agent of Formula (IV). This invention also relates to the compound of Formula (IV) as well as to a process to obtain it. The cross-linked poly(allylamine) polymers of the invention are useful in medicine as substrate-binding polymers.

Drugs covered by this patent

Patent Metadata

Patent number
EP2016947A1
Jurisdiction
EP
Classification
—
Expires
2009-01-21
Drug substance claim
No
Drug product claim
No
Assignee
Chemo Iberica SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.